SCHEMBL856642

SCHEMBL856642

OCCC1CCc2c(Cl)ncnc2C1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
HTR2B P41595 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL857217 0.88 HTR2A (0.33) HTR2AHTR2CHTR2B
SCHEMBL857577 0.81 KDM4E (0.38) HTR2AHTR2CHTR2B
SCHEMBL857578 0.81 KDM4E (0.38) HTR2AHTR2CHTR2B
SCHEMBL859174 0.78 HTR2A (0.32) HTR2AHTR2CHTR2B
SCHEMBL858845 0.72 LIMK1 (0.41) HTR2AHTR2CHTR2B
SCHEMBL855219 0.72 LIMK1 (0.41) HTR2AHTR2CHTR2B
SCHEMBL855220 0.72 LIMK1 (0.41) HTR2AHTR2CHTR2B
SCHEMBL15112226 0.72 NPC1 (0.44)
SCHEMBL15112485 0.72 NPC1 (0.44)
SCHEMBL15112353 0.72 NPC1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2640366-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE Exelixis, Inc. (US) 2013-09-25 EP disclosed
WO-2012068096-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE EXELIXIS, INC. (US) 2012-05-24 WO disclosed
EP-2432779-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES Exelixis, Inc. (US) 2012-03-28 EP disclosed
WO-2010135524-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES EXELIXIS, INC. (US) 2010-11-25 WO disclosed